Protalix BioTherapeutics
PLX
#5635
Rank
$0.03 B
Marketcap
$0.83
Share price
-0.80%
Change (1 day)
-81.52%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: $0.03 Billion

As of January 2022 Protalix BioTherapeutics has a market cap of $0.03 Billion. This makes Protalix BioTherapeutics the world's 5635th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 2001 to 2022

Year Market cap Change
2022$0.03 B-9.49%
2021$0.04 B-64.24%
2020$0.12 B148.64%
2019$0.04 B5.47%
2018$0.04 B-50.05%
2017$0.09 B67.73%
2016$0.05 B-45.89%
2015$0.10 B-40.9%
2014$0.17 B-52.64%
2013$0.36 B-25.05%
2012$0.48 B14.95%
2011$0.42 B-47.68%
2010$0.80 B50.76%
2009$0.53 B283.05%
2008$0.13 B-45.77%
2007$0.25 B-75.03%
2006$1.03 B4063.51%
2005$0.02 B4150%
2004$0.58 M-50%
2003$1.16 M263.64%
2002$0.32 M-52.17%
2001$0.67 M

End of Day market cap according to different sources

On Jan 20th, 2022 the market cap of Protalix BioTherapeutics was reported to be:

$0.03 Billion
by Yahoo Finance
$0.03 Billion
by CompaniesMarketCap
$0.03 Billion
by Nasdaq
$0.03 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap difference Country
$303.37 B 799,049.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.90 B 18,092.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.56 B 6,660.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.80 B 25,734.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel